Autonomous University of Barcelona at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Autonomous University of Barcelona brings 2 presentations to ESGCT 2026 in Hamburg. Its work covers AAV gene therapy for brain and metabolic conditions, including glial delivery that reverses signs of megalencephalic leukoencephalopathy and shows how promoter choice affects safety. Another strand expresses secreted klotho to support healthy ageing in non-human primates.
| Organization | ESGCT 2026 Attendance |
|---|---|
Autonomous University of Barcelona Bellaterra, Spain | |
Public university near Barcelona whose gene therapy groups develop AAV treatments for neurological and metabolic diseases. | Poster Wed Oct 28 1:30pm–3:30pm Human secreted klotho expression supports healthy aging in non-human primates Poster Thu Oct 29 2:00pm–4:00pm Systemic AAV9P31-mediated glial gene therapy reverses major pathological hallmarks of megalencephalic leukoencephalopathy and reveals promoter selection as a key determinant of gene therapy safety Chair Thu Oct 29 4:00pm–6:00pm SESSION 9a: CNS & sensory II Rare and inherited disease |
Instantly find 20 buyers from Autonomous University of Barcelona
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction